Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1771 to 1785 of 2186 results for guidelines

  1. Liraglutide for the treatment of type 2 diabetes mellitus (TA203)

    This guidance has been updated and replaced by NICE guideline NG28.

  2. Statins for the prevention of cardiovascular events (TA94)

    This guidance has been updated and replaced by NICE guideline CG181.

  3. Looked-after children and young people (PH28)

    This guidance has been updated and replaced by NICE guideline NG205.

  4. Sexually transmitted infections and under-18 conceptions: prevention (PH3)

    This guidance has been updated and replaced by NICE guideline NG221.

  5. HIV testing: increasing uptake in black Africans (PH33)

    This guidance has been updated and replaced by NICE guideline NG60.

  6. Substance misuse interventions for vulnerable under 25s (PH4)

    This guidance has been updated and replaced by NICE guideline NG64.

  7. Community engagement (PH9)

    This guidance has been updated and replaced by NICE guideline NG44.

  8. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

  9. Febuxostat for the management of hyperuricaemia in people with gout (TA164)

    This guidance has been updated and replaced by NICE guideline NG219.

  10. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

    This guidance has been updated and replaced by NICE guideline NG158.

  11. Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)

    This guidance has been updated and replaced by NICE guideline NG195.

  12. Crohn's disease: management (CG152)

    This guidance has been updated and replaced by NICE guideline NG129.

  13. Ectopic pregnancy and miscarriage: diagnosis and initial management (CG154)

    This guidance has been updated and replaced by NICE guideline NG126

  14. Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia (CG157)

    This guidance has been updated and replaced by NICE guideline NG203.